Last News RECORDATI: OWN SHARE PURCHASE PROGRAM FOR THE STOCK OPTION PLANS Financial news and new initiatives Who we are Recordati is an established international pharmaceutical group, partner of important companies. >> Rare diseases Every patient with a rare disease has the right to the best possible treatment. >> Research and development With an eye to the future, the Recordati Group makes substantial investments in research and development. >> International presence Recordati in the world, an international development strategy. >> Partnering Always committed to the creation of future value through a careful policy of alliances >> The Recordati - Investors Share “The most valuable currency in the financial markets is reliable information”. (Michael Bloomberg, Mary Shapiro) >> Annual balance Institutional Brochure The Prize Alert Service Italian | English Company data RECORDATI SpA VIA M. CIVITALI, 1 - 20148 MILAN, ITALY SHARE CAPITAL € 26,140,644.5 fully paid up REG. IMP. MILAN, MONZA, BRIANZA and LODI 00748210150 TAX CODE / P. VAT number 00748210150 REA MILANO 401832 Company Subject to the management and coordination of Rossini Luxembourg S.à rl delivered by Tech Style Site Services Alert service Legal notices Privacy Policy Latest news October 29, 2021 RECORDATI: PROGRAM FOR THE PURCHASE OF TREASURY SHARES FOR THE STOCK OPTION PLANS October 28, 2021 RECORDATI: APPROVATI RISULTATI DEI PRIMI NOVE MESI DEL 2021. RICAVI +5,7%, EBITDA +2,1% E UTILE NETTO +8,1%. PROSEGUE LA RIPRESA INIZIATA NEL SECONDO TRIMESTRE